Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.

Suppr

超能文献

作者信息

Gertz M A, Falk R H, Skinner M, Cohen A S, Kyle R A

出版信息

Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1645. doi: 10.1016/0002-9149(85)90995-6.

DOI:10.1016/0002-9149(85)90995-6

PMID:4003314

Abstract

摘要

相似文献

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.

Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1645. doi: 10.1016/0002-9149(85)90995-6.

Calcium antagonist caution.

Lancet. 1991 Apr 13;337(8746):885-6.

Calcium channel blockers in left ventricular dysfunction or congestive heart failure.

Conn Med. 1997 Oct;61(10):659-61.

Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.

Am J Cardiol. 1998 Jan 15;81(2):163-9. doi: 10.1016/s0002-9149(97)00868-0.

Experience with calcium antagonist drugs in congestive heart failure.

Am J Cardiol. 1987 Jan 30;59(3):64B-69B. doi: 10.1016/0002-9149(87)90084-1.

[Calcium channel blockers and mild congestive heart failure: advantage or disadvantage?].

Duodecim. 1991;107(22):1872-5.

Calcium antagonists in heart failure.

Eur Heart J. 1988 Jun;9 Suppl H:101-4. doi: 10.1093/eurheartj/9.suppl_h.101.

Studies with felodipine in congestive heart failure.

Drugs. 1985;29 Suppl 2:66-75. doi: 10.2165/00003495-198500292-00013.

[Calcium antagonists in congestive heart failure].

G Ital Cardiol. 1988 Nov;18(11):989-96.

[Effect of the calcium antagonist nifangin on hemodynamics in patients with congestive heart failure].

Kardiologiia. 1989 May;29(5):23-7.

引用本文的文献

Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report.

Int J Emerg Med. 2024 Oct 21;17(1):159. doi: 10.1186/s12245-024-00750-x.

2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.

Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.

Cardiac amyloidosis: state-of-the-art review.

J Geriatr Cardiol. 2023 May 28;20(5):361-375. doi: 10.26599/1671-5411.2023.05.006.

Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.

BMJ Case Rep. 2023 Apr 20;16(4):e250972. doi: 10.1136/bcr-2022-250972.

Amyloidosis of the Heart and Kidney.

Methodist Debakey Cardiovasc J. 2022 Sep 6;18(4):27-33. doi: 10.14797/mdcvj.1150. eCollection 2022.

Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.

Herz. 2022 Aug;47(4):324-331. doi: 10.1007/s00059-022-05122-w. Epub 2022 Jun 8.

Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.

Front Cardiovasc Med. 2022 May 17;9:863179. doi: 10.3389/fcvm.2022.863179. eCollection 2022.

Cardiac Amyloidosis Treatment.

Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):59-72. doi: 10.14797/mdcvj.1050. eCollection 2022.

Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.

JACC CardioOncol. 2021 Aug 17;3(4):522-533. doi: 10.1016/j.jaccao.2021.05.004. eCollection 2021 Oct.

ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review.

JACC CardioOncol. 2021 Oct 19;3(4):488-505. doi: 10.1016/j.jaccao.2021.06.006. eCollection 2021 Oct.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents.

Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1645. doi: 10.1016/0002-9149(85)90995-6.

Calcium antagonist caution.

Lancet. 1991 Apr 13;337(8746):885-6.

Calcium channel blockers in left ventricular dysfunction or congestive heart failure.

Conn Med. 1997 Oct;61(10):659-61.

Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.

Am J Cardiol. 1998 Jan 15;81(2):163-9. doi: 10.1016/s0002-9149(97)00868-0.

Experience with calcium antagonist drugs in congestive heart failure.

Am J Cardiol. 1987 Jan 30;59(3):64B-69B. doi: 10.1016/0002-9149(87)90084-1.

[Calcium channel blockers and mild congestive heart failure: advantage or disadvantage?].

Duodecim. 1991;107(22):1872-5.

Calcium antagonists in heart failure.

Eur Heart J. 1988 Jun;9 Suppl H:101-4. doi: 10.1093/eurheartj/9.suppl_h.101.

Studies with felodipine in congestive heart failure.

Drugs. 1985;29 Suppl 2:66-75. doi: 10.2165/00003495-198500292-00013.

[Calcium antagonists in congestive heart failure].

G Ital Cardiol. 1988 Nov;18(11):989-96.

[Effect of the calcium antagonist nifangin on hemodynamics in patients with congestive heart failure].

Kardiologiia. 1989 May;29(5):23-7.

引用本文的文献

Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report.

Int J Emerg Med. 2024 Oct 21;17(1):159. doi: 10.1186/s12245-024-00750-x.

2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.

Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.

Cardiac amyloidosis: state-of-the-art review.

J Geriatr Cardiol. 2023 May 28;20(5):361-375. doi: 10.26599/1671-5411.2023.05.006.

Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.

BMJ Case Rep. 2023 Apr 20;16(4):e250972. doi: 10.1136/bcr-2022-250972.

Amyloidosis of the Heart and Kidney.

Methodist Debakey Cardiovasc J. 2022 Sep 6;18(4):27-33. doi: 10.14797/mdcvj.1150. eCollection 2022.

Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.

Herz. 2022 Aug;47(4):324-331. doi: 10.1007/s00059-022-05122-w. Epub 2022 Jun 8.

Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.

Front Cardiovasc Med. 2022 May 17;9:863179. doi: 10.3389/fcvm.2022.863179. eCollection 2022.

Cardiac Amyloidosis Treatment.

Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):59-72. doi: 10.14797/mdcvj.1050. eCollection 2022.

Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.

JACC CardioOncol. 2021 Aug 17;3(4):522-533. doi: 10.1016/j.jaccao.2021.05.004. eCollection 2021 Oct.

ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review.

JACC CardioOncol. 2021 Oct 19;3(4):488-505. doi: 10.1016/j.jaccao.2021.06.006. eCollection 2021 Oct.